Share Eli Lilly raised its sales outlook as diabetes and obesity demand lifted quarterly revenue 39%, but acquisition-related research costs reduced its profit forecast.
$LLY INSIGHTS →

lly · signals · earnings · 3 min read · ♡ 63 · ▢ 8 · ↗ 0

Eli Lilly raised its sales outlook as diabetes and obesity demand lifted quarterly revenue 39%, but acquisition-related research costs reduced its profit forecast.

· App research preview · Editorial standards

Read the full research in the app

A subscription is required to access the full thread.

Open in the app →
Financials
Technicals
Earnings-peers